Mr. Speaker, a study was undertaken by Mandato et al to evaluate the safety of outpatient treatment in almost 250 patients with multiple sclerosis and CCSVI. The study shows that treatment of CCSVI is a safe procedure, with a 1.6% risk of major complications. The petitioners call on the Minister of Health to consult experts actively engaged in diagnosis and treatment of CCSVI, to undertake phase III clinical trials in multiple centres across Canada and to require follow-up care.
In the House of Commons on February 1st, 2012. See this statement in context.